Redhill Biopharma Stock Filter Stocks by Fundamentals
RDHL Stock | USD 0.46 0.01 1.78% |
Redhill Biopharma fundamentals help investors to digest information that contributes to Redhill Biopharma's financial success or failures. It also enables traders to predict the movement of Redhill Stock. The fundamental analysis module provides a way to measure Redhill Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Redhill Biopharma stock.
Redhill | Shares Owned by Insiders |
Redhill Biopharma Institutional Holders
Institutional Holdings refers to the ownership stake in Redhill Biopharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Redhill Biopharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Redhill Biopharma's value.Shares | Advisor Group Holdings, Inc. | 2023-12-31 | 104 | Ubs Group Ag | 2023-12-31 | 104 | Bank Of America Corp | 2023-12-31 | 82.0 | Atlantic Edge Private Wealth Management Llc | 2023-12-31 | 25.0 | Wells Fargo & Co | 2023-12-31 | 23.0 | Jpmorgan Chase & Co | 2023-12-31 | 8.0 | Ifp Advisors, Llc | 2023-12-31 | 7.0 | Cowen And Company, Llc | 2023-09-30 | 0.0 | Virtu Financial Llc | 2023-12-31 | 0.0 | Gagnon Securities Llc | 2023-12-31 | 89.6 K | Jane Street Group, Llc | 2023-12-31 | 86.8 K |
Redhill Fundamentals
Return On Equity | -8.84 | ||||
Return On Asset | -0.16 | ||||
Profit Margin | 3.66 % | ||||
Operating Margin | (10.61) % | ||||
Current Valuation | 3.61 B | ||||
Shares Outstanding | 31.87 M | ||||
Shares Owned By Institutions | 6.24 % | ||||
Number Of Shares Shorted | 741.45 K | ||||
Price To Earning | (3.67) X | ||||
Price To Book | 6.55 X | ||||
Price To Sales | 2.08 X | ||||
Revenue | 6.51 M | ||||
Gross Profit | 45.25 M | ||||
EBITDA | (29.37 M) | ||||
Net Income | 23.85 M | ||||
Cash And Equivalents | 28.86 M | ||||
Cash Per Share | 0.55 X | ||||
Total Debt | 1.17 M | ||||
Debt To Equity | 9.89 % | ||||
Current Ratio | 0.98 X | ||||
Book Value Per Share | 0.10 X | ||||
Cash Flow From Operations | (35.73 M) | ||||
Short Ratio | 1.79 X | ||||
Earnings Per Share | 4.00 X | ||||
Target Price | 760.0 | ||||
Number Of Employees | 53 | ||||
Beta | 3.46 | ||||
Market Capitalization | 14.62 M | ||||
Total Asset | 23.05 M | ||||
Retained Earnings | (407.74 M) | ||||
Working Capital | (3.1 M) | ||||
Current Asset | 60.51 M | ||||
Current Liabilities | 5.51 M | ||||
Net Asset | 23.05 M |
About Redhill Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Redhill Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Redhill Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Redhill Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Redhill Biopharma is a strong investment it is important to analyze Redhill Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Redhill Biopharma's future performance. For an informed investment choice regarding Redhill Stock, refer to the following important reports:Check out Redhill Biopharma Piotroski F Score and Redhill Biopharma Altman Z Score analysis. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.Note that the Redhill Biopharma information on this page should be used as a complementary analysis to other Redhill Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Redhill Stock analysis
When running Redhill Biopharma's price analysis, check to measure Redhill Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redhill Biopharma is operating at the current time. Most of Redhill Biopharma's value examination focuses on studying past and present price action to predict the probability of Redhill Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redhill Biopharma's price. Additionally, you may evaluate how the addition of Redhill Biopharma to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Global Correlations Find global opportunities by holding instruments from different markets |
Is Redhill Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 4 | Revenue Per Share 1.008 | Quarterly Revenue Growth (0.96) | Return On Assets (0.16) | Return On Equity (8.84) |
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.